1
|
Mateo M, Reynard S, Baillet N, Carnec X, Fizet A, Jourdain M, Picard C, Schaeffer J, Barrot L, Barron S, Vallve A, Raoul H, Carbonnelle C, Tangy F, Baize S. One-shot immunization using a Measles/Lassa vaccine fully protects cynomolgus monkeys against Lassa fever. Int J Infect Dis 2019. [DOI: 10.1016/j.ijid.2018.11.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
2
|
Zuily S, Rat AC, Regnault V, Kaminsky P, Mismetti P, Ninet J, Baillet N, Magy-Bertrand N, Pasquali JL, Lambert M, Pasquier E, Lorcerie B, Lecompte T, Guillemin F, Wahl D. Impairment of quality of life in patients with antiphospholipid syndrome. Lupus 2015; 24:1161-8. [PMID: 25862730 DOI: 10.1177/0961203315580871] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2014] [Accepted: 03/17/2015] [Indexed: 11/15/2022]
Abstract
OBJECTIVES Health-related quality of life (HRQoL) has not been fully explored in antiphospholipid syndrome (APS); therefore, we compared HRQoL between APS patients and the general population and assessed the impact of thromboembolic history. METHODS HRQoL was measured in a multicentre cohort study by the Medical Outcomes Study Short-Form 36 (MOS-SF-36) questionnaire. HRQoL scores were compared to the French general population norms. Factors significantly associated with an impaired HRQoL were identified. RESULTS A total of 115 patients with aPL and/or systemic lupus erythematosus (SLE) were included (mean age 42.7 ± 14.1 years old, 86 women). In 53 patients APS was diagnosed. Compared to general population norms, patients with APS had an impaired HRQoL. SLE-associated APS patients had the worst HRQoL scores (physical component summary (PCS)=40.8 ± 10.6; mental component summary (MCS)=40.6 ± 16.5) in comparison with SLE or aPL patients without thromboembolic history. In APS patients, history of arterial thrombosis significantly impaired HRQoL (PCS score: 42.2 ± 9.4 vs 49.2 ± 8.5; MCS score: 33.9 ± 13.7 vs 44.6 ± 10.3). CONCLUSION Compared to the general population, APS patients experienced a lower HRQoL. In these patients, a history of arterial thrombosis significantly impaired HRQoL. Therefore, measurements of HRQoL should be included in APS patient management to assess the burden of the disease from a patient's perspective and to provide patients with the support they need.
Collapse
Affiliation(s)
- S Zuily
- CHU de Nancy, Vascular Medicine Division and Regional Competence Centre for Systemic and Autoimmune Diseases, Nancy, France Inserm, UMR_S 1116, Nancy, France Université de Lorraine, Nancy, France
| | - A-C Rat
- Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Nancy, France Inserm, CIC-EC CIE6, Nancy, France CHU de Nancy, Clinical Epidemiology and Evaluation Department, Nancy, France CHU de Nancy, Rheumatology Department, Nancy, France
| | - V Regnault
- Inserm, UMR_S 1116, Nancy, France Université de Lorraine, Nancy, France CHU de Nancy, Contrat d'interface, Nancy, France
| | - P Kaminsky
- Université de Lorraine, Nancy, France CHU de Nancy, Orphan Disease Unit, Nancy, France
| | - P Mismetti
- CHU de Saint Etienne, Clinical Pharmacology Unit and EA 3065, Saint-Etienne, France
| | - J Ninet
- CHU de Lyon, Department of Internal Medicine, Lyon, France
| | - N Baillet
- Colmar Hospital, Department of Internal Medicine, Colmar, France
| | - N Magy-Bertrand
- CHU de Besançon, Internal Medicine and Clinical Immunology Department, Besançon, France
| | - J-L Pasquali
- CHU de Strasbourg, Internal Medicine and Clinical Immunology Department, Strasbourg, France
| | - M Lambert
- CHRU de Lille, Department of Internal Medicine, Lille, France
| | - E Pasquier
- CHU de Brest, Department of Internal Medicine and Chest Diseases and EA 3878, Brest, France
| | - B Lorcerie
- CHU de Dijon, Internal Medicine and Clinical Immunology Department, Dijon, France
| | - T Lecompte
- Université de Lorraine, Nancy, France University Hospitals of Geneva, Division of Haematology, Geneva, Switzerland (T.L. current address)
| | - F Guillemin
- Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Nancy, France CHU de Nancy, Clinical Epidemiology and Evaluation Department, Nancy, France
| | - D Wahl
- CHU de Nancy, Vascular Medicine Division and Regional Competence Centre for Systemic and Autoimmune Diseases, Nancy, France Inserm, UMR_S 1116, Nancy, France Université de Lorraine, Nancy, France
| | | |
Collapse
|